Chicago, ILLINOIS4 Active Studies

COVID-19 Clinical Trials in Chicago, ILLINOIS

Find 4 actively recruiting covid-19 clinical trials in Chicago, ILLINOIS. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
942
Enrolling

Recruiting COVID-19 Studies in Chicago

RecruitingChicago, ILLINOISNCT07013474

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelvir alone and in combination with remdesivir IV comp...

300 participants
Pfizer
View Study Details
RecruitingChicago, ILLINOISNCT03808922

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19....

274 participants
Ansun Biopharma, Inc.
View Study Details
RecruitingChicago, ILLINOISNCT06847191

NE3107 in Adults With Neurological Symptoms of Long COVID

Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in ...

208 participants
BioVie Inc.
View Study Details
RecruitingChicago, ILLINOISNCT05261139

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and ef...

160 participants
Pfizer
View Study Details

About COVID-19 Clinical Trials in Chicago

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that primarily affects the respiratory system. Long COVID (PASC) involves persistent symptoms weeks or months after initial infection. Treatment includes antiviral medications, monoclonal antibodies, and supportive care.

There are currently 4 covid-19 clinical trials recruiting participants in Chicago, ILLINOIS. These studies are seeking a combined 942 participants. Research is being sponsored by Pfizer, Ansun Biopharma, Inc., BioVie Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

COVID-19 Clinical Trials in Chicago — FAQ

Are there covid-19 clinical trials in Chicago?

Yes, there are 4 covid-19 clinical trials currently recruiting in Chicago, ILLINOIS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What covid-19 treatments are being tested?

The 4 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for covid-19.

Data updated March 2, 2026 from ClinicalTrials.gov